Dhamasa in Ayurveda: Properties & Everyday Use

What it is

Dhamasa is the whole plant of Fagonia cretica L. (family Zygophyllaceae), a small, spiny shrub of arid regions of India, Pakistan, and the Middle East. Modern pharmacological reviews describe it as a traditional herb with reported immunomodulatory, anti-inflammatory, antimicrobial, and hepatoprotective functions in traditional health-care use (Journal of Advanced Scientific Research). Phytochemical profiling identifies flavonoids, phenolics, and saponins among its bioactive constituents (BMC Complementary Medicine and Therapies, 2024).

Classical properties

• Taste (rasa): bitter (Tikta), astringent (Kashaya)
• Qualities (guna): light (Laghu), dry (Ruksha)
• Potency (virya): cooling (Sheeta)
• After digestion (vipaka): pungent (Katu)
• Doshas: traditionally said to settle Pitta and Kapha; may increase Vata

Traditional use

In traditional practice, Fagonia cretica is described as a cooling, bitter herb of liver and general care; a recent integrative review surveys its traditional and pharmacological background across Ayurvedic and regional systems (Pharmaceuticals/MDPI review, 2026). An Indian pharmacological paper describes its reported functions as immunomodulatory, anti-inflammatory, antimicrobial, and hepatoprotective (JASR). These are traditional descriptions, not clinical proof: no human trials were found.

What research has looked at

Inflammation (in vitro)

A 2024 study tested an alcoholic extract of F. cretica for anti-inflammatory potential by measuring inhibition of COX-1, COX-2, and nitric oxide production, finding inhibition of these targets, with celecoxib, indomethacin, and ascorbic acid run as reference standards (BMC Complementary Medicine and Therapies). Enzyme-inhibition in a test tube is a mechanistic hint only: it does not show the herb reduces inflammation in people.

Cell-killing effects (in vitro)

The same study evaluated the extract against three human carcinoma cell lines (breast MCF-7, liver HepG2, colon CACO2), finding the strongest inhibitory activity against MCF-7, with evidence of topoisomerase I inhibition and caspase-9–mediated apoptosis induction (BMC Complementary Medicine and Therapies). These are cell-culture results; they are not evidence that Dhamasa treats or prevents cancer in humans.

Ulcerative colitis (animal)

In mice with dextran-sulfate-sodium–induced ulcerative colitis, ethanolic extract of F. cretica significantly improved body weight and colon length, reduced the disease activity index (1.28 vs 3.87 in disease controls) and colon mucosal damage index (1.40 vs 3.40), lowered the inflammatory marker myeloperoxidase, and raised antioxidant enzymes (SOD, catalase); the study also included the drug sulphasalazine as a comparison (JASR). This is a single mouse study; human relevance is unknown, and Dhamasa is not a treatment for colitis. Never use it in place of, or alongside, prescribed medicine without your doctor.

Blood clotting and mood (animal)

A 2026 integrative review reports that in rat models, F. cretica markedly prolonged clotting time (an anticoagulant-like effect) and showed moderate, dose-dependent anti-inflammatory activity (MDPI Pharmaceuticals review). These are animal findings with no human confirmation.

Safety notes

No published human safety studies of Dhamasa exist, and there are no reliable data on safety in pregnancy or breastfeeding. One caution comes from animal data: because F. cretica prolonged clotting time in rats, it could theoretically add to the effects of blood-thinning medications or increase bleeding risk around surgery (MDPI review): a hypothesis from animal work, not an established interaction. Safety data is limited: talk to a clinician before use, especially if you take anticoagulants or are scheduled for surgery.

FAQs

What is Dhamasa?

Dhamasa is the Ayurvedic name for Fagonia cretica L., a small spiny shrub of arid regions, used whole in traditional practice for inflammatory and liver-related conditions (JASR; MDPI review). Phytochemical profiling identifies flavonoids, phenolics, and saponins among its constituents, and no human trials were found (BMC Complementary Medicine and Therapies).

Does Dhamasa fight inflammation?

In the lab, its extract inhibited the inflammatory enzymes COX-1 and COX-2 and nitric oxide production (BMC Complementary Medicine and Therapies), and a mouse colitis study showed reduced intestinal inflammation (JASR). There is no human evidence it reduces inflammation in people.

Can Dhamasa treat cancer?

No. Its extract inhibited human breast (MCF-7), liver (HepG2), and colon (CACO2) cancer cells in culture, with evidence of topoisomerase I inhibition and caspase-9–mediated apoptosis (BMC Complementary Medicine and Therapies). Cell-culture results are not evidence of cancer treatment, and no published human cancer trials exist.

Is there any human evidence for Dhamasa?

None was found. All modern evidence, anti-inflammatory enzyme inhibition in vitro, cytotoxicity in cancer cell lines, anti-colitis effects in mice, and anticoagulant-like clotting changes in rats, comes from laboratory or animal studies (BMC Complementary Medicine and Therapies; JASR; MDPI review). No human trials were found in the published literature.

Does Dhamasa thin the blood?

In rats, F. cretica markedly prolonged clotting time, suggesting an anticoagulant-like effect in animals (MDPI review). This has not been studied in humans, but it is a reason for caution with blood thinners and before surgery: discuss with a clinician. This is a hypothesis from animal work, not an established drug interaction.

Is Dhamasa safe?

No published human safety studies exist, and there are no reliable data on pregnancy, breastfeeding, or drug interactions. The only caution beyond the unknown comes from animal data suggesting a possible anticoagulant-like effect, so extra caution applies with blood-thinning medications or before surgery (MDPI review). Safety data is limited: talk to a clinician before use.

Sources

• "Validating anti-inflammatory and cytotoxic properties of Fagonia cretica L. through metabolic, in vitro, and in silico profiling." BMC Complementary Medicine and Therapies, 2024 — link.springer.com (full text: PMC · PMC11603770)
• "Evaluation of effect of ethanolic extract of Fagonia cretica L. plant against experimentally induced ulcerative colitis in mice." Journal of Advanced Scientific Research — sciensage.info
• "Fagonia cretica L. and Redox Homeostasis: An Integrative Review of Phytochemistry, Redox-Sensitive Signaling, and Pharmacological Potential." Pharmaceuticals (MDPI), 2026 — mdpi.com

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.